Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alcon Inc

Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact.

Benzinga · Aug 20, 2025

3 Medical Device Stocks to Buy for Consistent Growth

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements. In this evolving landscape, investors could scoop up shares of robust medical device stocks Alcon (ALC), Becton, Dickinson (BDX), and Abbott (ABT) for solid gains. Read more….

StockNews.com · Oct 18, 2024

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

StockNews.com · Sep 5, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Veeva Systems (VEEV) vs. Alcon (ALC) Earnings Watch: Which Medical Stock Is the Better Pick?

In the fast-paced world of healthcare, where aging population and technological leaps are driving significant growth in the sector, which of the two medical stocks, Veeva Systems (VEEV) and Alcon Inc. (ALC), could emerge as the better prescription for your portfolio? Let's find out….

StockNews.com · Feb 27, 2024

Assessing Alcon Inc.’s (ALC) Post-Earnings Prospects: Is It Time to Invest, Hold, or Let Go?

Is Swiss eye care leader Alcon Inc. (ALC) a buy, hold, or sell after its third-quarter earnings release yesterday? Let’s look at its financial metrics to gauge its prospects….

StockNews.com · Nov 16, 2023

Is This Eye Care Stock a Buy as It Strikes $770M Buyout?

Swiss eye care company Alcon (ALC) recently announced that it would acquire Aerie Pharmaceuticals (AERI) for $770 million. The deal is expected to help bolster ALC’s expansion into the ophthalmic pharmaceutical space. So, will it be wise to invest in the stock now? Read on to learn our view….

StockNews.com · Aug 26, 2022

People

Dipanjan BanchurSince

722 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Becton, Dickinson, and Company

Medical – Devices & Equipment

14 stories

Medical Devices Equipment

Read news from The Economist, FT, and more,
with one subscription

Places

United States

419,641 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.